The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2024 | Clinicians’ knowledge and awareness of PROs in immune thrombocytopenia: results of a national survey
Esther Oliva, MD, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy, comments on a national survey conducted in Italy that investigated clinicians’ knowledge and awareness of the importance of patient-reported outcomes (PROs) in immune thrombocytopenia (ITP). Dr Oliva highlights that, unlike many younger physicians, senior hematologists and experienced clinicians recognize the value of PROs in assessing patient well-being and making informed treatment decisions. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
This was a survey that was sent out to ITP treating physicians in Italy. What we were assessing was their knowledge of patient-reported outcomes, both in clinical practice and in research. To summarize, what we found was that younger physicians and those with less experience were those that valued patient-reported outcomes less and had less knowledge. The senior hematologists and those who take care of ITP patients for a long time valued the assessment of patients and actually recommended assessing those who are not feeling well, those who are fragile, because the patient-reported outcome measures can give very valuable information...
This was a survey that was sent out to ITP treating physicians in Italy. What we were assessing was their knowledge of patient-reported outcomes, both in clinical practice and in research. To summarize, what we found was that younger physicians and those with less experience were those that valued patient-reported outcomes less and had less knowledge. The senior hematologists and those who take care of ITP patients for a long time valued the assessment of patients and actually recommended assessing those who are not feeling well, those who are fragile, because the patient-reported outcome measures can give very valuable information. This was not perceived by younger physicians. Therefore, the recommendation is to provide training to physicians at an early stage to incorporate patient-reported outcomes into their clinical practice, and not only in research.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
Disclosures
Grande Ospedale Metropolitano Bianchi Melacrino Morelli: Current Employment; Daiichi Sankyo: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria, Speakers Bureau; Janssen: Speakers Bureau; Halia Therapeutics: Patents & Royalties; Novartis: Consultancy, Honoraria, Speakers Bureau; Amgen: Consultancy, Honoraria, Speakers Bureau; Sobi: Consultancy, Honoraria, Speakers Bureau; Alexion: Consultancy, Honoraria, Speakers Bureau; Ryvu: Consultancy, Honoraria, Patents & Royalties.
